VA HB 486
Status unknownMedical care facilities; expanded access to medical cannabis for terminally ill patients.
Virginia · 2026 Regular Session · lower
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did VA HB 486 pass?
The current status of VA HB 486 is not known from the official record. Latest recorded action (2026-02-12): Incorporated by Health and Human Services (HB75-Keys-Gamarra) (Voice Vote)
What is VA HB 486 about?
Medical care facilities; expanded access to medical cannabis for terminally ill patients. Requires medical care facilities to permit terminally ill patients, as defined in the bill, to use medical cannabis. The bill requires medical care facilities to adopt policies facilitating the use of medical cannabis. The provisions of the bill do not apply to the provision of emergency medical services, including in emergency departments of hospitals. The bill requires compliance with applicable drug and medication requirements, specifies that compliance with its provisions shall not be a condition of obtaining, retaining, or renewing a license as a medical care facility, and establishes a protocol for noncompliance in the event of intervention by the federal government. The bill has a delayed effective date contingent on the federal rescheduling of marijuana from a Schedule I to a Schedule III drug. This bill was incorporated into HB 75.
Who sponsors VA HB 486?
Irene Shin is the primary sponsor of VA HB 486, joined by 3 cosponsors.
Description
Medical care facilities; expanded access to medical cannabis for terminally ill patients. Requires medical care facilities to permit terminally ill patients, as defined in the bill, to use medical cannabis. The bill requires medical care facilities to adopt policies facilitating the use of medical cannabis. The provisions of the bill do not apply to the provision of emergency medical services, including in emergency departments of hospitals. The bill requires compliance with applicable drug and medication requirements, specifies that compliance with its provisions shall not be a condition of obtaining, retaining, or renewing a license as a medical care facility, and establishes a protocol for noncompliance in the event of intervention by the federal government. The bill has a delayed effective date contingent on the federal rescheduling of marijuana from a Schedule I to a Schedule III drug. This bill was incorporated into HB 75.
- Introduced
- 2026-01-12
- Latest action
- 2026-02-12 — Incorporated by Health and Human Services (HB75-Keys-Gamarra) (Voice Vote)
- Bill type
- bill
- Last updated
- —
Sponsors
- Irene Shinprimary
- Garrett McGuirecosponsor
- Kelly K. Convirs-Fowlercosponsor
- Michelle Lopes Maldonadocosponsor
Committees
Not provided by source.
Action timeline
Newest first
2026-02-12
Incorporated by Health and Human Services (HB75-Keys-Gamarra) (Voice Vote)
2026-02-10
Subcommittee recommends incorporating (Voice Vote)
2026-02-10
House subcommittee offered
2026-01-30
Fiscal Impact Statement from Department of Planning and Budget (HB486)
2026-01-21
Assigned sub: Health
referral-committee
2026-01-12
Referred to Committee on Health and Human Services
referral-committee
2026-01-12
Prefiled and ordered printed; Offered 01-14-2026 26104839D
filing,introduction
Versions
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:35:59.552682Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=VA&identifier=HB 486. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.